Getinge introduces Poladus 150 – the future of low-temperature sterilization

Report this content

Today, Getinge unveils the Poladus 150, its latest innovation in low-temperature sterilization, designed for heat-sensitive surgical instruments. Equipped with advanced cross-contamination barrier technology, Poladus 150 plays a crucial role in preventing healthcare acquired infections (HCAIs).

Getinge’s new Vaporized Hydrogen Peroxide (VH2O2) low-temp sterilizer Poladus 150 operates within a gentle temperature of up to 55°C, ensuring that non-lumen, flexible lumen, and rigid lumen instruments are ready for the next surgery.

“Today marks a significant milestone for our Infection Control business. The Poladus 150 materializes our ambition to be a leading player in the field of VH2O2 low-temperature sterilization, which is one of the most dynamic segments, with the development of more and more advanced endoscopic and robotic procedures. This product launch is a great addition to our portfolio for central sterile supply departments (CSSDs),” says Stéphane Le Roy, President of Surgical Workflows at Getinge.

The newcomer brings forth a host of achievements and benefits that set new standards in the sterile reprocessing field.

“It offers competitive sterilization claims and capacity, ensuring a safe and effective way of reprocessing both flexible and rigid instruments used in endoscopy and surgical operations,” says Sophia Brüggemann, Product Manager at Getinge.

The sterilizer’s innovative Cross-Contamination Barrier (CCB) design ensures separate air flows in different zones, preventing the spread of harmful bacteria and viruses. This reduces the risk of cross-contamination and helps prevent HCAI, which pose a significant risk to patients and can result in severe complications and prolonged hospital stays.

“We have prioritized operator well-being and efficiency with features like a comfortable loading height, automated bottle hatch, foot switch for hands-free operation, and an RFID reader for seamless user identification,” Sophia explains.

Getinge’s Poladus 150 is designed to be a high performer to ensure a seamless workflow for hospitals. Its rapid pre-heating time, large chamber capacity, and dimensions are tailored for the high demands of CSSD environments.

“With the Poladus 150, we are offering high throughput without compromising on quality or safety, ensuring that hospitals can keep up with their sterile reprocessing needs,” Sophia adds.

Connectivity and instrument traceability are also at the forefront of the Poladus 150’s benefits. It connects with FleetView, a device lifecycle management tool, and with T-DOC, Getinge’s sterile supply management software. This integration streamlines hospital device management, allowing instrument tracking with ease.

To complement the Poladus 150, Getinge will offer a wide range of low-temp consumables, including H2O2 sterilant, biological and chemical indicators, VH2O2 tape, and Tyvek® rolls and pouches. These consumables are designed to ensure safe sterile reprocessing and a smooth workflow.

Sophia emphasizes the holistic approach of the Poladus 150:

“We are introducing a comprehensive sterilization ecosystem that enhances the workflow and safety of healthcare providers around the world.”

Discover Poladus 150 >>

This text is intended to provide information to an international audience outside the US.

Media contact:

Caroline Örmgård, Head of Public & Media Relations
Phone: +46 (0)10 335 0041
Email:
 caroline.ormgard@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.

Tags:

Subscribe

Media

Media

Quotes

Today marks a significant milestone for our Infection Control business. The Poladus 150 materializes our ambition to be a leading player in the field of VH2O2 low-temperature sterilization, which is one of the most dynamic segments, with the development of more and more advanced endoscopic and robotic procedures.
President of Surgical Workflows at Getinge